Midi vs Alloy: Which Menopause Telehealth Is Right for You?

If you have spent any time researching menopause telehealth, two names keep surfacing: Midi Health and Alloy. They are both built specifically for women in midlife, both staffed by clinicians trained in menopause, and both can get you a hormone therapy prescription without an in-person visit. On the surface they look like competitors solving the same problem. In practice, they are built on two genuinely different business models, and that single difference (how you pay) is what should drive your choice.

The short version: Midi bills your insurance and offers broader midlife medical care, while Alloy is a flat cash-pay service with FDA-approved medications included in transparent, predictable pricing. Neither is "better" in the abstract. The right answer depends on your insurance situation, how much hand-holding you want, and whether you need menopause care specifically or a wider midlife medical home. Let's break it down honestly, including where each one falls short.

The core difference: insurance-billed care vs. cash-pay simplicity

Everything else flows from this one distinction, so it is worth getting clear.

Midi Health operates like a virtual medical practice. It is available in all 50 states and is in-network with many PPO plans and some Medicare Advantage plans. When your insurance applies, your video visits may cost only a standard copay, sometimes as low as $0 to $30, and your prescriptions are sent to a regular pharmacy where your insurance can also apply. If you are paying out of pocket, Midi's self-pay visits run roughly $250 for an initial consult and around $150 for follow-ups (as of 2026, confirm current pricing on Midi's site, since these change). Midi also tends to use blood work and live video appointments as part of its clinical process.

Alloy takes the opposite approach. It does not bill insurance at all. Instead, you pay a modest one-time fee to consult with a menopause-trained physician (around $49 to $50, as of 2026), and then you pay directly for the medications you are prescribed. Estrogen products, for example, have been priced in the range of roughly $40 to $75 for a multi-month supply, with shipping included. The medication price effectively is the membership; there is no separate ongoing platform fee for standard hormone therapy. Much of Alloy's care happens asynchronously through secure messaging rather than a scheduled video call, and it generally does not require lab work to start basic HRT.

So the mental model is simple. Midi is "use my insurance and give me a real clinician relationship." Alloy is "tell me the price up front, include the meds, and keep it simple."

At-a-glance decision matrix

Treat these figures as 2026 ranges, not quotes. Both companies adjust pricing, and your real cost with Midi depends entirely on your specific plan. Always verify on the provider's own page before you commit.

Where Midi shines, and where it frustrates

Midi's biggest strength is that it functions as a true midlife medical home. Beyond hormone therapy for hot flashes, sleep, and mood, Midi clinicians also handle weight management, bone health and osteoporosis risk, and other concerns that cluster in the 45 to 55 window. If you want one place that can order a bone density test, talk through your sleep, and manage a GLP-1 alongside your hormones, that breadth is real value. Midi has cared for hundreds of thousands of women and reflects mainstream guidance from bodies like The Menopause Society and ACOG in its clinical approach.

The insurance angle is the other major draw. If you have a PPO that Midi is in-network with, you can get specialist-level menopause care for ordinary copays, which can be dramatically cheaper over a year than any cash-pay option. For many insured women, that alone makes Midi the obvious starting point. You can read our fuller writeup in the Midi Health review for 2026.

Now the honest cons. The most consistent complaint in Midi's public reviews is billing. In public reviews, Midi draws strong praise for clinicians who actually listen, but a meaningful share of critical reviews cite unexpected charges, billing confusion, and slower portal communication (check the current rating and review count yourself on sites like Trustpilot, since they shift over time). Insurance-billed telehealth is inherently more complex than a flat fee, and some patients get surprised by costs they did not anticipate. If predictability matters more to you than breadth, that is a genuine strike against Midi. It is worth calling your insurer first to confirm Midi is in-network and asking exactly what visits will cost.

Where Alloy shines, and where it falls short

Alloy's superpower is predictability. You know the price before you start, the medications are FDA-approved and shipped to your door, and there is no insurance claim to decode afterward. For women without strong menopause coverage, or anyone who simply hates billing surprises, that transparency is a real relief. The asynchronous model is also a fit for busy lives: you can describe your symptoms and history through the portal on your own schedule instead of booking a video slot. And because Alloy works exclusively with FDA-approved products for its core HRT, you sidestep a lot of the confusion around compounding. (If you want to understand that distinction, see compounded vs. FDA-approved HRT.)

Alloy's catalog covers the menopause essentials well: systemic estradiol, vaginal estrogen for genitourinary symptoms, progesterone for women with a uterus, and testosterone options. It has also built out a dedicated Weight Care program (around $99 per month plus medication, as of 2026) offering GLP-1 options including FDA-approved Wegovy and Zepbound alongside other formats. We cover how hormones and these drugs interact in our GLP-1 and HRT combination guide.

The honest limitations: Alloy is narrower than Midi. It is excellent at menopause and weight, but it is not designed to be your comprehensive primary care or to manage complex, multi-system conditions. The cash-pay model also means you carry the full cost yourself; if you have generous insurance, Alloy may end up more expensive than using your benefits elsewhere. And the asynchronous, messaging-first style that many women love can feel impersonal to someone who wants a face-to-face conversation and a continuous relationship with one named clinician. You can still use HSA or FSA dollars, which softens the cash-pay sting, but it is not the same as insurance covering the visit.

A note on GLP-1s and the 2026 regulatory reality

Both providers offer weight care that may include GLP-1 medications like semaglutide and tirzepatide, and this deserves a clear-eyed caveat. These are prescription medications that require evaluation by a licensed clinician and typically have eligibility criteria, often a BMI threshold (commonly 30, or 27 with a weight-related condition). They are not something to order casually.

The compounding landscape also changed. After the FDA declared the semaglutide and tirzepatide shortages resolved, the broad, large-scale compounding of these drugs that flourished during the shortage is now restricted. Some compounded access continues in specific, legally narrow circumstances, but the rules are tighter than they were a year or two ago. Reputable providers like Midi and Alloy navigate this through licensed pharmacies, and you should expect a real clinical evaluation. Never buy GLP-1s, "research peptides," or gray-market hormones from sellers who skip the prescription step. The FDA has repeatedly warned about counterfeit and unapproved products. If a deal looks too easy, that is the warning sign. For the bigger picture, browse our treatments overview.

How to choose: a simple framework

Lean Midi if: you have a PPO or Medicare Advantage plan that may cover the visits, you want one clinician who can address menopause plus weight, bone health, and other midlife issues together, and you value live video appointments and a continuous relationship. The trade-off is that you accept more billing complexity in exchange for that breadth and potential insurance savings.

Lean Alloy if: you are paying cash anyway, you want to know the total cost before you start, you prefer the convenience of messaging-based care, and your main needs are hormone therapy and possibly weight support. The trade-off is a narrower scope and no insurance to lean on.

A practical tip: do the math for a full year, not a single visit. With Midi, call your insurer and confirm network status and copays first; an in-network year can be very affordable. With Alloy, add the consult fee plus twelve months of your likely medications. Then compare apples to apples. Our treatment comparison tool can help you line up options side by side, and our guide to insurance coverage by provider goes deeper on what tends to be covered.

Whichever way you lean, come prepared. Write down your symptoms, their severity, your personal and family health history (especially blood clots, breast cancer, heart disease, and stroke), and your current medications. Our free appointment prep tool walks you through it so your first consult, whether a Midi video call or an Alloy intake, is efficient and complete.

The bottom line

This is not a case of one winner. Midi and Alloy are both legitimate, menopause-focused options that follow mainstream clinical guidance, and the choice between them is mostly about how you want to pay and how much breadth you need. If you have solid insurance and want a comprehensive midlife medical home, start with Midi. If you want transparent cash pricing, FDA-approved meds included, and low-friction messaging care, start with Alloy. If neither feels quite right, there are other strong players worth comparing in our telehealth HRT directory and our broader 2026 telehealth HRT comparison. The most important step is simply starting the conversation with a qualified clinician about treatment you have likely been managing alone for too long.

"Midi vs. Alloy really comes down to one question: do you want to use your insurance and get broad midlife care, or pay a flat cash price for menopause meds with no surprises?"

FindMyHRT is an independent directory. Some links to providers are partnerships and we may earn a commission at no extra cost to you. This never affects who we list or how we rank them. See our Affiliate Disclosure.

Medical Disclaimer: This article is for general educational purposes only and is not medical advice. Hormone therapy, GLP-1 medications, and menopause treatment decisions are individual and should be made with a qualified healthcare provider who knows your full history. Prescription medications require evaluation by a licensed clinician. Always consult your provider before starting or changing any treatment.